Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine and Oxybutynin for Post-Nasal Drip in Seasonal Allergic Rhinitis
NCT00816972Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Apr 2005
- Primary completion
- Jun 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of desloratadine, oxybutynin in post-nasal drip (PND), seasonal allergic rhinitis (SAR), sponsored by Organon & Co.. Started Apr 2005; status: completed.
02
Drugs
desloratadineoxybutynin
03
Conditions
post-nasal drip (PND)seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00816972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00816972.